NeutriSci International Inc (NU) - Total Assets

Latest as of September 2023: CA$127.83K CAD ≈ $92.47K USD

Based on the latest financial reports, NeutriSci International Inc (NU) holds total assets worth CA$127.83K CAD (≈ $92.47K USD) as of September 2023. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check how aggressively does NeutriSci International Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

NeutriSci International Inc - Total Assets Trend (2001–2022)

This chart illustrates how NeutriSci International Inc's total assets have evolved over time, based on quarterly financial data. Check NeutriSci International Inc (NU) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

NeutriSci International Inc - Asset Composition Analysis

Current Asset Composition (December 2022)

NeutriSci International Inc's total assets of CA$127.83K consist of 60.1% current assets and 39.9% non-current assets.

Asset Category	Amount (CAD)	% of Total Assets
Cash & Equivalents	CA$0.00	52.9%
Accounts Receivable	CA$8.81K	2.7%
Inventory	CA$15.00K	4.5%
Property, Plant & Equipment	CA$132.34K	39.9%
Intangible Assets	CA$0.00	0.0%
Goodwill	CA$0.00	0.0%

Asset Composition Trend (2001–2022)

This chart illustrates how NeutriSci International Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see NU company net worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: NeutriSci International Inc's current assets represent 60.1% of total assets in 2022, a decrease from 100.0% in 2001.
Cash Position: Cash and equivalents constituted 52.9% of total assets in 2022, down from 99.5% in 2001.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2001.
Asset Diversification: The largest asset category is property, plant & equipment at 39.9% of total assets.

NeutriSci International Inc Competitors by Total Assets

Key competitors of NeutriSci International Inc based on total assets are shown below.

Company	Country	Total Assets
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Aurobindo Pharma Limited NSE:AUROPHARMA	India	Rs585.02 Billion
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	China	CN¥14.18 Billion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	China	CN¥10.37 Billion
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	China	CN¥7.28 Billion
Xeris Pharmaceuticals Inc NASDAQ:XERS	USA	$392.01 Million
Procter & Gamble Health Limited NSE:PGHL	India	Rs8.94 Billion

NeutriSci International Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	0.02	0.16	1.91
Quick Ratio	0.01	0.02	1.48
Cash Ratio	0.00	0.00	0.00
Working Capital	CA$-911.80K	CA$-677.67K	CA$251.41K

NeutriSci International Inc - Advanced Valuation Insights

This section examines the relationship between NeutriSci International Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	20.28
Latest Market Cap to Assets Ratio	2.69
Asset Growth Rate (YoY)	-59.6%
Total Assets	CA$331.43K
Market Capitalization	$892.12K USD

Valuation Analysis

Premium Asset Valuation: The market values NeutriSci International Inc's assets at a significant premium (2.69x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: NeutriSci International Inc's assets decreased by 59.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for NeutriSci International Inc (2001–2022)

The table below shows the annual total assets of NeutriSci International Inc from 2001 to 2022.

Year	Total Assets	Change
2022-12-31	CA$331.43K ≈ $239.75K	-59.56%
2021-12-31	CA$819.51K ≈ $592.82K	+55.13%
2020-12-31	CA$528.28K ≈ $382.15K	+4.65%
2019-12-31	CA$504.81K ≈ $365.18K	-8.80%
2018-12-31	CA$553.55K ≈ $400.43K	-7.91%
2017-12-31	CA$601.12K ≈ $434.84K	-47.27%
2016-12-31	CA$1.14 Million ≈ $824.62K	-33.18%
2015-12-31	CA$1.71 Million ≈ $1.23 Million	-33.35%
2014-12-31	CA$2.56 Million ≈ $1.85 Million	-60.74%
2014-09-30	CA$6.52 Million ≈ $4.72 Million	+1180.85%
2012-12-31	CA$508.96K ≈ $368.18K	+298.53%
2011-12-31	CA$127.71K ≈ $92.38K	+39.96%
2010-12-31	CA$91.25K ≈ $66.01K	-45.82%
2009-12-31	CA$168.42K ≈ $121.83K	-7.88%
2008-12-31	CA$182.84K ≈ $132.26K	-13.46%
2007-12-31	CA$211.28K ≈ $152.84K	-60.19%
2006-12-31	CA$530.74K ≈ $383.93K	+49.66%
2005-12-31	CA$354.63K ≈ $256.54K	-9.55%
2004-12-31	CA$392.07K ≈ $283.62K	-70.10%
2003-12-31	CA$1.31 Million ≈ $948.54K	+664.22%
2002-12-31	CA$171.58K ≈ $124.12K	-50.35%
2001-12-31	CA$345.55K ≈ $249.97K	--

About NeutriSci International Inc

V:NU Canada Drug Manufacturers - Specialty & Generic

Market Cap

$1.50 Billion

CA$2.07 Billion CAD

Market Cap Rank

#30581 Global

#1604 in Canada

Share Price

CA$11.62

Change (1 day)

-2.19%

52-Week Range

CA$11.60 - CA$18.76

All Time High

CA$18.76